Search Results
Educational Resources
AIDS is a collection of symptoms known as acquired immunodeficiency syndrome.
Fact Sheet
Pharmacogenomics is a growing area of genomic medicine that uses a patient's genomic information to help healthcare providers select the medications and dosages that are predicted to work best in each patient.
… More than 6% of hospital admissions are due to adverse drug reactions, and avoiding such adverse reactions using … testing can be used to determine if the tumor cells in a cancer patient have a specific version of a receptor, which … receptor called HER2, which is called HER2-positive breast cancer.  HER2 receptors can cause the cancer to grow and …
Event
On February 16, 2023, the National Human Genome Research Institute (NHGRI) held a follow-up working group consultation after the 14th Genomic Medicine meeting, Genomic Medicine XIV: Genomic Learning Healthcare Systems.
… It almost never gets used. We have CDS for >30 gene-drug pairs in our EHR; this may be relevant, but is not … from 3 different departments (Medical Genetics, Cancer Genetics, and PreventiveGenomics) were available to … care.  We see a broad range of patients from hereditary cancer risk assessment, pharmacogenomics, carrier …
Genomics and Medicine
Starting in 2019, the American Journal of Human Genetics has published an annual feature identifying ten key advances in applying genomic information to clinical care that were reported in the previous 12 months of published literature. The Genomic Medicine Working Group has authored these reviews, based on its broader effort to identify notable accomplishments in genomic medicine on a monthly basis. From this larger set of published accomplishments, the working group has continued to select ten papers annually to be highlighted as the most significant.
… with gene editing 7. Validation of a clinical breast cancer risk assessment tool for all ancestries 8. Broader … with rare diseases 9. Benefits for children with suspected cancer from routine whole-genome sequencing 10. Clinical … care Pharmacogenetic intervention reduces serious adverse drug events Natural language processing helps to prioritize …
The Genomics Landscape
In the May 2024 issue of The Genomics Landscape, NHGRI Director Eric Green talks about the NHGRI Research Training and Career Development Annual Meeting, which provides a venue to foster support and a sense of community for NHGRI-funded trainees, equipping them with tools for success and more clarity about career possibilities.
… cell biology and the development of certain diseases, like cancer. Centromeres have long been challenging to … anniversary of the fellows program. … Genomics Research Drug shows promise for slowing progression of rare, painful … develop AI tool with potential to more precisely match cancer drugs to patients  Notable accomplishments in genomic …
Research at NHGRI
Families Sharing Health Assessment and Risk Evaluation (SHARE) helps you and your family learn how your family health history affects your risk for diseases.
… Colorectal Cancer Breast Cancer Prostate Cancer Type 2 Diabetes Heart Disease How to Use the Families … to reduce risk of heart disease, diabetes, breast cancer, and colorectal cancer . BMC Public Health,  15: …
FAQ
Questions and answers from the September 26, 2022, Multi-Omics for Health and Disease Consortium Pre-Application Webinar.
… both tumor and normal tissues from participants with cancer are strongly encouraged and will be prioritized for … setting this up could take some time. … Biosamples For the cancer DSS, can we propose just plasma collection and no … Collection of tumor samples from participants with cancer is encouraged but it is not a strict requirement. See …
The Genomics Landscape
In the September 2021 issue of The Genomics Landscape, NHGRI Director, Eric Green, M.D., Ph.D., details how social media provides NHGRI staff with a space to talk about their work, make genomics topics easy to understand, and show how genomics can positively affect people.
… the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) to gather information about some … those using artificial intelligence. The National Cancer Institute will host this virtual event on September …
Clinical Research
A study for patients with unexpected genetic results
… unexpected genetic test results about their risk for cancer, heart disease, and other conditions after having … treated or prevented. Many of these results are related to cancer risk and heart conditions . If you think you have … or Spanish  Received a genetic testing result related to cancer risk or heart disease even though they were not …
For Health Professionals
The ISCC-PEG Pharmacogenomics (PGx) Project Group has developed peer-reviewed online education for healthcare practitioners to advance pharmacogenomics in clinical practice.
… evidence-based pharmacogenomic resources from the Food and Drug Administration (FDA), the Clinical Pharmacogenetics … safety of psychiatric medications as well as the impact of drug-drug interactions (phenoconversion) through case-based …